This inventor holds 1 USPTO granted patent. Top assignee: Ascendis Pharma Oncology Division A/s. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Harald Rau
Introduction
Harald Rau is a notable inventor based in Heidelberg, Denmark. He has made significant contributions to the field of oncology through his innovative work. With a focus on developing advanced therapeutic solutions, Rau has secured his place in the realm of medical inventions.
Latest Patents
One of Harald Rau's key patents is related to IL-2 Conjugates. This invention represents a significant advancement in cancer treatment, showcasing his commitment to improving patient outcomes. Rau holds 1 patent that reflects his expertise and dedication to innovation in the medical field.
Career Highlights
Harald Rau is currently associated with Ascendis Pharma Oncology Division A/S. His role in this esteemed company allows him to collaborate with other experts in the field, further enhancing his contributions to oncology. Rau's work is characterized by a strong focus on developing effective therapies that can make a difference in patients' lives.
Collaborations
One of his notable coworkers is Nicola Bisek. Together, they work on various projects aimed at advancing cancer treatment options. Their collaboration exemplifies the importance of teamwork in the field of medical research and innovation.
Conclusion
Harald Rau's contributions to the field of oncology through his patent on IL-2 Conjugates and his work at Ascendis Pharma Oncology Division A/S highlight his dedication to improving cancer therapies. His innovative spirit and collaborative efforts continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile